{
    "URL": "https://doi.org/10.1371/journal.pntd.0010433",
    "Published": "May 27, 2022",
    "Subject_Areas": [
        "Macaque",
        "Vaccination and immunization",
        "Viral vaccines",
        "Infectious disease control",
        "Vaccine development",
        "Antibodies",
        "Vesicular stomatitis virus",
        "Ebola virus"
    ],
    "Authors": {
        "Courtney Woolsey": [
            "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America",
            "Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Robert W. Cross": [
            "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America",
            "Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Krystle N. Agans": [
            "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America",
            "Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Viktoriya Borisevich": [
            "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America",
            "Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Daniel J. Deer": [
            "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America",
            "Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Joan B. Geisbert": [
            "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America",
            "Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Cheryl Gerardi": [
            "Department of Viral Vaccine Development, Auro Vaccines, Pearl River, New York, United States of America"
        ],
        "Theresa E. Latham": [
            "Department of Viral Vaccine Development, Auro Vaccines, Pearl River, New York, United States of America"
        ],
        "Karla A. Fenton": [
            "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America",
            "Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Michael A. Egan": [
            "Department of Immunology, Auro Vaccines, Pearl River, New York, United States of America"
        ],
        "John H. Eldridge": [
            "Department of Immunology, Auro Vaccines, Pearl River, New York, United States of America"
        ],
        "Thomas W. Geisbert": [
            "Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America",
            "Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, United States of America"
        ],
        "Demetrius Matassov": [
            "Department of Viral Vaccine Development, Auro Vaccines, Pearl River, New York, United States of America"
        ]
    }
}